Request for Covid-19 Impact Assessment of this Report
The United States Medical Antifungal Agent market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Medical Antifungal Agent market, reaching US$ million by the year 2028. As for the Europe Medical Antifungal Agent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Medical Antifungal Agent players cover Novartis, Pfizer, Bayer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Antifungal Agent market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Azoles
Echinocandins
Polyenes
Allylamines
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Dermatophytosis
Aspergillosis
Candidiasis
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Antifungal Agent Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Medical Antifungal Agent by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Medical Antifungal Agent by Country/Region, 2017, 2022 & 2028
2.2 Medical Antifungal Agent Segment by Type
2.2.1 Azoles
2.2.2 Echinocandins
2.2.3 Polyenes
2.2.4 Allylamines
2.2.5 Others
2.3 Medical Antifungal Agent Sales by Type
2.3.1 Global Medical Antifungal Agent Sales Market Share by Type (2017-2022)
2.3.2 Global Medical Antifungal Agent Revenue and Market Share by Type (2017-2022)
2.3.3 Global Medical Antifungal Agent Sale Price by Type (2017-2022)
2.4 Medical Antifungal Agent Segment by Application
2.4.1 Dermatophytosis
2.4.2 Aspergillosis
2.4.3 Candidiasis
2.4.4 Others
2.5 Medical Antifungal Agent Sales by Application
2.5.1 Global Medical Antifungal Agent Sale Market Share by Application (2017-2022)
2.5.2 Global Medical Antifungal Agent Revenue and Market Share by Application (2017-2022)
2.5.3 Global Medical Antifungal Agent Sale Price by Application (2017-2022)
3 Global Medical Antifungal Agent by Company
3.1 Global Medical Antifungal Agent Breakdown Data by Company
3.1.1 Global Medical Antifungal Agent Annual Sales by Company (2020-2022)
3.1.2 Global Medical Antifungal Agent Sales Market Share by Company (2020-2022)
3.2 Global Medical Antifungal Agent Annual Revenue by Company (2020-2022)
3.2.1 Global Medical Antifungal Agent Revenue by Company (2020-2022)
3.2.2 Global Medical Antifungal Agent Revenue Market Share by Company (2020-2022)
3.3 Global Medical Antifungal Agent Sale Price by Company
3.4 Key Manufacturers Medical Antifungal Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Antifungal Agent Product Location Distribution
3.4.2 Players Medical Antifungal Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Antifungal Agent by Geographic Region
4.1 World Historic Medical Antifungal Agent Market Size by Geographic Region (2017-2022)
4.1.1 Global Medical Antifungal Agent Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Medical Antifungal Agent Annual Revenue by Geographic Region
4.2 World Historic Medical Antifungal Agent Market Size by Country/Region (2017-2022)
4.2.1 Global Medical Antifungal Agent Annual Sales by Country/Region (2017-2022)
4.2.2 Global Medical Antifungal Agent Annual Revenue by Country/Region
4.3 Americas Medical Antifungal Agent Sales Growth
4.4 APAC Medical Antifungal Agent Sales Growth
4.5 Europe Medical Antifungal Agent Sales Growth
4.6 Middle East & Africa Medical Antifungal Agent Sales Growth
5 Americas
5.1 Americas Medical Antifungal Agent Sales by Country
5.1.1 Americas Medical Antifungal Agent Sales by Country (2017-2022)
5.1.2 Americas Medical Antifungal Agent Revenue by Country (2017-2022)
5.2 Americas Medical Antifungal Agent Sales by Type
5.3 Americas Medical Antifungal Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Antifungal Agent Sales by Region
6.1.1 APAC Medical Antifungal Agent Sales by Region (2017-2022)
6.1.2 APAC Medical Antifungal Agent Revenue by Region (2017-2022)
6.2 APAC Medical Antifungal Agent Sales by Type
6.3 APAC Medical Antifungal Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Antifungal Agent by Country
7.1.1 Europe Medical Antifungal Agent Sales by Country (2017-2022)
7.1.2 Europe Medical Antifungal Agent Revenue by Country (2017-2022)
7.2 Europe Medical Antifungal Agent Sales by Type
7.3 Europe Medical Antifungal Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Antifungal Agent by Country
8.1.1 Middle East & Africa Medical Antifungal Agent Sales by Country (2017-2022)
8.1.2 Middle East & Africa Medical Antifungal Agent Revenue by Country (2017-2022)
8.2 Middle East & Africa Medical Antifungal Agent Sales by Type
8.3 Middle East & Africa Medical Antifungal Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Antifungal Agent
10.3 Manufacturing Process Analysis of Medical Antifungal Agent
10.4 Industry Chain Structure of Medical Antifungal Agent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Antifungal Agent Distributors
11.3 Medical Antifungal Agent Customer
12 World Forecast Review for Medical Antifungal Agent by Geographic Region
12.1 Global Medical Antifungal Agent Market Size Forecast by Region
12.1.1 Global Medical Antifungal Agent Forecast by Region (2023-2028)
12.1.2 Global Medical Antifungal Agent Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Antifungal Agent Forecast by Type
12.7 Global Medical Antifungal Agent Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Medical Antifungal Agent Product Offered
13.1.3 Novartis Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Medical Antifungal Agent Product Offered
13.2.3 Pfizer Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Medical Antifungal Agent Product Offered
13.3.3 Bayer Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Medical Antifungal Agent Product Offered
13.4.3 Sanofi Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Merck & Co
13.5.1 Merck & Co Company Information
13.5.2 Merck & Co Medical Antifungal Agent Product Offered
13.5.3 Merck & Co Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck & Co Main Business Overview
13.5.5 Merck & Co Latest Developments
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Information
13.6.2 GlaxoSmithKline Medical Antifungal Agent Product Offered
13.6.3 GlaxoSmithKline Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GlaxoSmithKline Main Business Overview
13.6.5 GlaxoSmithKline Latest Developments
13.7 MSD Manuals
13.7.1 MSD Manuals Company Information
13.7.2 MSD Manuals Medical Antifungal Agent Product Offered
13.7.3 MSD Manuals Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 MSD Manuals Main Business Overview
13.7.5 MSD Manuals Latest Developments
13.8 Abbott
13.8.1 Abbott Company Information
13.8.2 Abbott Medical Antifungal Agent Product Offered
13.8.3 Abbott Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Abbott Main Business Overview
13.8.5 Abbott Latest Developments
13.9 Glenmark
13.9.1 Glenmark Company Information
13.9.2 Glenmark Medical Antifungal Agent Product Offered
13.9.3 Glenmark Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Glenmark Main Business Overview
13.9.5 Glenmark Latest Developments
13.10 Enzon Pharmaceuticals
13.10.1 Enzon Pharmaceuticals Company Information
13.10.2 Enzon Pharmaceuticals Medical Antifungal Agent Product Offered
13.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Enzon Pharmaceuticals Main Business Overview
13.10.5 Enzon Pharmaceuticals Latest Developments
13.11 Astellas Pharma
13.11.1 Astellas Pharma Company Information
13.11.2 Astellas Pharma Medical Antifungal Agent Product Offered
13.11.3 Astellas Pharma Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Astellas Pharma Main Business Overview
13.11.5 Astellas Pharma Latest Developments
13.12 Scynexis
13.12.1 Scynexis Company Information
13.12.2 Scynexis Medical Antifungal Agent Product Offered
13.12.3 Scynexis Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Scynexis Main Business Overview
13.12.5 Scynexis Latest Developments
13.13 Cidara Therapeutics
13.13.1 Cidara Therapeutics Company Information
13.13.2 Cidara Therapeutics Medical Antifungal Agent Product Offered
13.13.3 Cidara Therapeutics Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Cidara Therapeutics Main Business Overview
13.13.5 Cidara Therapeutics Latest Developments
13.14 Lucigen Corporation
13.14.1 Lucigen Corporation Company Information
13.14.2 Lucigen Corporation Medical Antifungal Agent Product Offered
13.14.3 Lucigen Corporation Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Lucigen Corporation Main Business Overview
13.14.5 Lucigen Corporation Latest Developments
13.15 Biosergen
13.15.1 Biosergen Company Information
13.15.2 Biosergen Medical Antifungal Agent Product Offered
13.15.3 Biosergen Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Biosergen Main Business Overview
13.15.5 Biosergen Latest Developments
13.16 F2G
13.16.1 F2G Company Information
13.16.2 F2G Medical Antifungal Agent Product Offered
13.16.3 F2G Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 F2G Main Business Overview
13.16.5 F2G Latest Developments
13.17 Sichuan Meidakang Pharmaceutical
13.17.1 Sichuan Meidakang Pharmaceutical Company Information
13.17.2 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product Offered
13.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Sichuan Meidakang Pharmaceutical Main Business Overview
13.17.5 Sichuan Meidakang Pharmaceutical Latest Developments
13.18 Chengdu Taihe Health Technology
13.18.1 Chengdu Taihe Health Technology Company Information
13.18.2 Chengdu Taihe Health Technology Medical Antifungal Agent Product Offered
13.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Chengdu Taihe Health Technology Main Business Overview
13.18.5 Chengdu Taihe Health Technology Latest Developments
14 Research Findings and Conclusion
Table 1. Medical Antifungal Agent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Medical Antifungal Agent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Azoles
Table 4. Major Players of Echinocandins
Table 5. Major Players of Polyenes
Table 6. Major Players of Allylamines
Table 7. Major Players of Others
Table 8. Global Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
Table 9. Global Medical Antifungal Agent Sales Market Share by Type (2017-2022)
Table 10. Global Medical Antifungal Agent Revenue by Type (2017-2022) & ($ million)
Table 11. Global Medical Antifungal Agent Revenue Market Share by Type (2017-2022)
Table 12. Global Medical Antifungal Agent Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
Table 14. Global Medical Antifungal Agent Sales Market Share by Application (2017-2022)
Table 15. Global Medical Antifungal Agent Revenue by Application (2017-2022)
Table 16. Global Medical Antifungal Agent Revenue Market Share by Application (2017-2022)
Table 17. Global Medical Antifungal Agent Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Medical Antifungal Agent Sales by Company (2020-2022) & (K Units)
Table 19. Global Medical Antifungal Agent Sales Market Share by Company (2020-2022)
Table 20. Global Medical Antifungal Agent Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Medical Antifungal Agent Revenue Market Share by Company (2020-2022)
Table 22. Global Medical Antifungal Agent Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Medical Antifungal Agent Producing Area Distribution and Sales Area
Table 24. Players Medical Antifungal Agent Products Offered
Table 25. Medical Antifungal Agent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Medical Antifungal Agent Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Medical Antifungal Agent Sales Market Share Geographic Region (2017-2022)
Table 30. Global Medical Antifungal Agent Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Medical Antifungal Agent Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Medical Antifungal Agent Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Medical Antifungal Agent Sales Market Share by Country/Region (2017-2022)
Table 34. Global Medical Antifungal Agent Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Medical Antifungal Agent Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)
Table 37. Americas Medical Antifungal Agent Sales Market Share by Country (2017-2022)
Table 38. Americas Medical Antifungal Agent Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Medical Antifungal Agent Revenue Market Share by Country (2017-2022)
Table 40. Americas Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
Table 41. Americas Medical Antifungal Agent Sales Market Share by Type (2017-2022)
Table 42. Americas Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
Table 43. Americas Medical Antifungal Agent Sales Market Share by Application (2017-2022)
Table 44. APAC Medical Antifungal Agent Sales by Region (2017-2022) & (K Units)
Table 45. APAC Medical Antifungal Agent Sales Market Share by Region (2017-2022)
Table 46. APAC Medical Antifungal Agent Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Medical Antifungal Agent Revenue Market Share by Region (2017-2022)
Table 48. APAC Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
Table 49. APAC Medical Antifungal Agent Sales Market Share by Type (2017-2022)
Table 50. APAC Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
Table 51. APAC Medical Antifungal Agent Sales Market Share by Application (2017-2022)
Table 52. Europe Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)
Table 53. Europe Medical Antifungal Agent Sales Market Share by Country (2017-2022)
Table 54. Europe Medical Antifungal Agent Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Medical Antifungal Agent Revenue Market Share by Country (2017-2022)
Table 56. Europe Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
Table 57. Europe Medical Antifungal Agent Sales Market Share by Type (2017-2022)
Table 58. Europe Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
Table 59. Europe Medical Antifungal Agent Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Medical Antifungal Agent Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Medical Antifungal Agent Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Medical Antifungal Agent Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Medical Antifungal Agent Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Medical Antifungal Agent Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Medical Antifungal Agent
Table 69. Key Market Challenges & Risks of Medical Antifungal Agent
Table 70. Key Industry Trends of Medical Antifungal Agent
Table 71. Medical Antifungal Agent Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Medical Antifungal Agent Distributors List
Table 74. Medical Antifungal Agent Customer List
Table 75. Global Medical Antifungal Agent Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Medical Antifungal Agent Sales Market Forecast by Region
Table 77. Global Medical Antifungal Agent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Medical Antifungal Agent Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Medical Antifungal Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Medical Antifungal Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Medical Antifungal Agent Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Medical Antifungal Agent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Medical Antifungal Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Medical Antifungal Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Medical Antifungal Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Medical Antifungal Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Medical Antifungal Agent Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Medical Antifungal Agent Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Medical Antifungal Agent Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Medical Antifungal Agent Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Medical Antifungal Agent Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Medical Antifungal Agent Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Medical Antifungal Agent Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Medical Antifungal Agent Revenue Market Share Forecast by Application (2023-2028)
Table 95. Novartis Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Medical Antifungal Agent Product Offered
Table 97. Novartis Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Pfizer Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 101. Pfizer Medical Antifungal Agent Product Offered
Table 102. Pfizer Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Pfizer Main Business
Table 104. Pfizer Latest Developments
Table 105. Bayer Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 106. Bayer Medical Antifungal Agent Product Offered
Table 107. Bayer Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Bayer Main Business
Table 109. Bayer Latest Developments
Table 110. Sanofi Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 111. Sanofi Medical Antifungal Agent Product Offered
Table 112. Sanofi Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Sanofi Main Business
Table 114. Sanofi Latest Developments
Table 115. Merck & Co Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 116. Merck & Co Medical Antifungal Agent Product Offered
Table 117. Merck & Co Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Merck & Co Main Business
Table 119. Merck & Co Latest Developments
Table 120. GlaxoSmithKline Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 121. GlaxoSmithKline Medical Antifungal Agent Product Offered
Table 122. GlaxoSmithKline Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. GlaxoSmithKline Main Business
Table 124. GlaxoSmithKline Latest Developments
Table 125. MSD Manuals Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 126. MSD Manuals Medical Antifungal Agent Product Offered
Table 127. MSD Manuals Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. MSD Manuals Main Business
Table 129. MSD Manuals Latest Developments
Table 130. Abbott Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 131. Abbott Medical Antifungal Agent Product Offered
Table 132. Abbott Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Abbott Main Business
Table 134. Abbott Latest Developments
Table 135. Glenmark Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 136. Glenmark Medical Antifungal Agent Product Offered
Table 137. Glenmark Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Glenmark Main Business
Table 139. Glenmark Latest Developments
Table 140. Enzon Pharmaceuticals Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 141. Enzon Pharmaceuticals Medical Antifungal Agent Product Offered
Table 142. Enzon Pharmaceuticals Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Enzon Pharmaceuticals Main Business
Table 144. Enzon Pharmaceuticals Latest Developments
Table 145. Astellas Pharma Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 146. Astellas Pharma Medical Antifungal Agent Product Offered
Table 147. Astellas Pharma Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Astellas Pharma Main Business
Table 149. Astellas Pharma Latest Developments
Table 150. Scynexis Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 151. Scynexis Medical Antifungal Agent Product Offered
Table 152. Scynexis Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. Scynexis Main Business
Table 154. Scynexis Latest Developments
Table 155. Cidara Therapeutics Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 156. Cidara Therapeutics Medical Antifungal Agent Product Offered
Table 157. Cidara Therapeutics Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Cidara Therapeutics Main Business
Table 159. Cidara Therapeutics Latest Developments
Table 160. Lucigen Corporation Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 161. Lucigen Corporation Medical Antifungal Agent Product Offered
Table 162. Lucigen Corporation Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 163. Lucigen Corporation Main Business
Table 164. Lucigen Corporation Latest Developments
Table 165. Biosergen Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 166. Biosergen Medical Antifungal Agent Product Offered
Table 167. Biosergen Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 168. Biosergen Main Business
Table 169. Biosergen Latest Developments
Table 170. F2G Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 171. F2G Medical Antifungal Agent Product Offered
Table 172. F2G Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 173. F2G Main Business
Table 174. F2G Latest Developments
Table 175. Sichuan Meidakang Pharmaceutical Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 176. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product Offered
Table 177. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 178. Sichuan Meidakang Pharmaceutical Main Business
Table 179. Sichuan Meidakang Pharmaceutical Latest Developments
Table 180. Chengdu Taihe Health Technology Basic Information, Medical Antifungal Agent Manufacturing Base, Sales Area and Its Competitors
Table 181. Chengdu Taihe Health Technology Medical Antifungal Agent Product Offered
Table 182. Chengdu Taihe Health Technology Medical Antifungal Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 183. Chengdu Taihe Health Technology Main Business
Table 184. Chengdu Taihe Health Technology Latest Developments
List of Figures
Figure 1. Picture of Medical Antifungal Agent
Figure 2. Medical Antifungal Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Antifungal Agent Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Medical Antifungal Agent Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Medical Antifungal Agent Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Azoles
Figure 10. Product Picture of Echinocandins
Figure 11. Product Picture of Polyenes
Figure 12. Product Picture of Allylamines
Figure 13. Product Picture of Others
Figure 14. Global Medical Antifungal Agent Sales Market Share by Type in 2021
Figure 15. Global Medical Antifungal Agent Revenue Market Share by Type (2017-2022)
Figure 16. Medical Antifungal Agent Consumed in Dermatophytosis
Figure 17. Global Medical Antifungal Agent Market: Dermatophytosis (2017-2022) & (K Units)
Figure 18. Medical Antifungal Agent Consumed in Aspergillosis
Figure 19. Global Medical Antifungal Agent Market: Aspergillosis (2017-2022) & (K Units)
Figure 20. Medical Antifungal Agent Consumed in Candidiasis
Figure 21. Global Medical Antifungal Agent Market: Candidiasis (2017-2022) & (K Units)
Figure 22. Medical Antifungal Agent Consumed in Others
Figure 23. Global Medical Antifungal Agent Market: Others (2017-2022) & (K Units)
Figure 24. Global Medical Antifungal Agent Sales Market Share by Application (2017-2022)
Figure 25. Global Medical Antifungal Agent Revenue Market Share by Application in 2021
Figure 26. Medical Antifungal Agent Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Medical Antifungal Agent Revenue Market Share by Company in 2021
Figure 28. Global Medical Antifungal Agent Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Medical Antifungal Agent Revenue Market Share by Geographic Region in 2021
Figure 30. Global Medical Antifungal Agent Sales Market Share by Region (2017-2022)
Figure 31. Global Medical Antifungal Agent Revenue Market Share by Country/Region in 2021
Figure 32. Americas Medical Antifungal Agent Sales 2017-2022 (K Units)
Figure 33. Americas Medical Antifungal Agent Revenue 2017-2022 ($ Millions)
Figure 34. APAC Medical Antifungal Agent Sales 2017-2022 (K Units)
Figure 35. APAC Medical Antifungal Agent Revenue 2017-2022 ($ Millions)
Figure 36. Europe Medical Antifungal Agent Sales 2017-2022 (K Units)
Figure 37. Europe Medical Antifungal Agent Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Medical Antifungal Agent Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Medical Antifungal Agent Revenue 2017-2022 ($ Millions)
Figure 40. Americas Medical Antifungal Agent Sales Market Share by Country in 2021
Figure 41. Americas Medical Antifungal Agent Revenue Market Share by Country in 2021
Figure 42. United States Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Medical Antifungal Agent Sales Market Share by Region in 2021
Figure 47. APAC Medical Antifungal Agent Revenue Market Share by Regions in 2021
Figure 48. China Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Medical Antifungal Agent Sales Market Share by Country in 2021
Figure 55. Europe Medical Antifungal Agent Revenue Market Share by Country in 2021
Figure 56. Germany Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Medical Antifungal Agent Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Medical Antifungal Agent Revenue Market Share by Country in 2021
Figure 63. Egypt Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Medical Antifungal Agent Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Medical Antifungal Agent in 2021
Figure 69. Manufacturing Process Analysis of Medical Antifungal Agent
Figure 70. Industry Chain Structure of Medical Antifungal Agent
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...